Estrella Immunopharma (ESLAW) Stock Chart & Stock Price History $0.10 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsSEC FilingsTrends Estrella Immunopharma Stock Price Performance5 Day Performance0.00%1 Month Performance+1.01%3 Month PerformanceN/A6 Month PerformanceN/AYear-To-Date Performance+233.33% Receive ESLAW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Sasco Gold LLCSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... [RUSH MY FREE GUIDE] ESLAW Stock Chart for Saturday, September, 7, 2024 ESLAW Chart by TradingView Estrella Immunopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/04/2024$0.10$0.10$0.10$0.063,200 shs$0.0009/03/2024$0.10$0.10$0.10$0.063,200 shs$0.0009/02/2024$0.10$0.10$0.10$0.092,000 shs$0.0008/30/2024$0.10$0.10$0.10$0.092,000 shs$0.0008/29/2024$0.09$0.10+17.65%$0.10$0.101,000 shs$0.0008/28/2024$0.08$0.09+13.33%$0.09$0.055,298 shs$0.00 Get the Latest News and Ratings for ESLAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 08/27/2024$0.04$0.08+87.50%$0.08$0.072,000 shs$0.0008/23/2024$0.10$0.04-59.96%$0.07$0.036,799 shs$0.0008/22/2024$0.10$0.10-3.85%$0.10$0.091,701 shs$0.0008/20/2024$0.10$0.10+4.00%$0.10$0.0810,401 shs$0.0008/19/2024$0.10$0.10-0.10%$0.10$0.104,700 shs$0.0008/16/2024$0.08$0.10+24.88%$0.10$0.085,000 shs$0.0008/15/2024$0.11$0.08-27.27%$0.11$0.083,002 shs$0.0008/14/2024$0.10$0.11+11.11%$0.11$0.114,502 shs$0.0008/12/2024$0.10$0.10$0.10$0.10100 shs$0.0008/09/2024$0.10$0.10$0.10$0.10100 shs$0.0008/08/2024$0.10$0.10$0.10$0.10185 shs$0.0008/07/2024$0.10$0.10$0.10$0.10185 shs$0.0008/06/2024$0.10$0.10$0.10$0.1086 shs$0.0008/05/2024$0.10$0.10$0.10$0.10100 shs$0.0008/02/2024$0.10$0.10-1.00%$0.10$0.10100 shs$0.0008/01/2024$0.10$0.10$0.10$0.1048 shs$0.0007/30/2024$0.10$0.10$0.19$0.0733,300 shs$0.0007/29/2024$0.10$0.10$0.10$0.10155 shs$0.0007/26/2024$0.04$0.10+150.00%$0.19$0.0733,399 shs$0.0007/25/2024$0.04$0.04+10.80%$0.04$0.042,456 shs$0.0007/24/2024$0.04$0.04+0.28%$0.04$0.048,218 shs$0.0007/22/2024$0.04$0.04$0.04$0.04100 shs$0.0007/10/2024$0.04$0.04$0.04$0.04100 shs$0.0007/08/2024$0.04$0.04$0.04$0.04100 shs$0.0007/05/2024$0.07$0.04-47.83%$0.04$0.04150 shs$0.0007/03/2024$0.07$0.07$0.08$0.073,000 shs$0.0007/01/2024$0.07$0.07$0.08$0.073,000 shs$0.0006/28/2024$0.07$0.07$0.08$0.073,000 shs$0.0006/27/2024$0.07$0.07$0.08$0.073,000 shs$0.0006/26/2024$0.07$0.07+1.62%$0.08$0.073,000 shs$0.0006/25/2024$0.05$0.07+33.14%$0.07$0.07972 shs$0.0006/24/2024$0.05$0.05$0.05$0.051,900 shs$0.0006/21/2024$0.05$0.05$0.05$0.051,957 shs$0.0006/20/2024$0.04$0.05+40.50%$0.05$0.051,957 shs$0.00Man who called 2008 crash: “The real bloodbath hasn’t even started” (Ad)Don't get blindsided by the coming storm.Take these four simple steps to save your retirement >>>06/18/2024$0.04$0.04$0.06$0.049,500 shs$0.0006/17/2024$0.04$0.04$0.06$0.049,500 shs$0.0006/14/2024$0.04$0.04-9.25%$0.06$0.049,513 shs$0.0006/13/2024$0.05$0.04-13.23%$0.04$0.043,407 shs$0.0006/12/2024$0.04$0.05+27.70%$0.06$0.053,492 shs$0.0006/11/2024$0.04$0.04-0.28%$0.05$0.043,533 shs$0.0006/10/2024$0.07$0.04-46.69%$0.04$0.04800 shs$0.00 Related Companies: 180 Life Sciences Stock Chart 60 Degrees Pharmaceuticals Stock Chart Alpha Tau Medical Stock Chart Anew Medical Stock Chart Apollomics Stock Chart BriaCell Therapeutics Stock Chart Cardio Diagnostics Stock Chart Carmell Stock Chart Celularity Stock Chart CERo Therapeutics Stock Chart Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLAW) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.